HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomasz Motyl Selected Research

6,6,8- trimethyl- 4,4a,5,6,7,7a,8,9- octahydrocyclopenta(4,5)cyclohepta(1,2- c)- furan- 4,8- diol 4- (N- tert- butoxycarbonyl- 3- phenylisoserinate)

8/2005Autophagy is the dominant type of programmed cell death in breast cancer MCF-7 cells exposed to AGS 115 and EFDAC, new sesquiterpene analogs of paclitaxel.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomasz Motyl Research Topics

Disease

17Neoplasms (Cancer)
08/2014 - 07/2004
11Breast Neoplasms (Breast Cancer)
06/2013 - 08/2005
5Neoplasm Metastasis (Metastasis)
01/2013 - 07/2006
2Pathologic Processes
06/2014 - 02/2009
1Heart Diseases (Heart Disease)
11/2013
1Adenocarcinoma
01/2013
1Carcinoma (Carcinomatosis)
09/2012
1Inflammation (Inflammations)
02/2012
1Hypoxia (Hypoxemia)
10/2011
1Starvation
10/2011
1Malnutrition (Nutritional Deficiencies)
09/2007
1Melanoma (Melanoma, Malignant)
08/2006
1Prostatic Neoplasms (Prostate Cancer)
08/2006
1Colonic Neoplasms (Colon Cancer)
11/2002

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
07/2013 - 07/2004
3Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA
02/2009 - 07/2006
2DNA (Deoxyribonucleic Acid)IBA
03/2012 - 02/2012
2AntigensIBA
02/2012 - 10/2011
2Cadherins (E-Cadherin)IBA
02/2009 - 07/2006
2Indicators and Reagents (Reagents)IBA
02/2009 - 08/2006
2Matrix Metalloproteinases (MMPs)IBA
02/2009 - 07/2006
2Estrogens (Estrogen)FDA Link
08/2006 - 07/2006
1SteroidsIBA
06/2014
1MicroRNAs (MicroRNA)IBA
01/2014
1Conditioned Culture MediaIBA
01/2014
1RelaxinIBA
07/2013
1Messenger RNA (mRNA)IBA
07/2013
1Cisplatin (Platino)FDA LinkGeneric
06/2013
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2013
1multidrug resistance-associated protein 1IBA
06/2013
1Vinblastine (Vinblastine Sulfate)FDA Link
06/2013
1Complement System Proteins (Complement)IBA
04/2013
1Annexin A5IBA
04/2013
1Macrophage Colony-Stimulating FactorIBA
04/2013
1Antineoplastic Agents (Antineoplastics)IBA
01/2013
1Therapeutic UsesIBA
01/2013
1Actins (F Actin)IBA
01/2013
1migrastatinIBA
01/2013
1GhrelinIBA
09/2012
1Biological ProductsIBA
09/2012
1Ghrelin ReceptorsIBA
09/2012
1matrigelIBA
03/2012
1CytokinesIBA
02/2012
1ChemokinesIBA
02/2012
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2011
1Semaphorins (Semaphorin)IBA
10/2011
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2011
1NeuropilinsIBA
10/2011
1Tissue Inhibitor of Metalloproteinase-2IBA
02/2009
1Hormones (Hormone)IBA
02/2009
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
02/2009
1Small Interfering RNA (siRNA)IBA
02/2009
1EnzymesIBA
02/2009
1progelatinaseIBA
02/2009
1Amino AcidsFDA Link
09/2007
1Glycoproteins (Glycoprotein)IBA
08/2006
1Biomarkers (Surrogate Marker)IBA
07/2006
1Steroid Receptors (Steroid Receptor)IBA
07/2006
1ProgesteroneFDA LinkGeneric
07/2006
1alpha Catenin (alpha E-Catenin)IBA
07/2006
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
01/2006
1Beclin-1IBA
01/2006
1CamptothecinIBA
01/2006
1Cathepsin BIBA
01/2006
16,6,8- trimethyl- 4,4a,5,6,7,7a,8,9- octahydrocyclopenta(4,5)cyclohepta(1,2- c)- furan- 4,8- diol 4- (N- tert- butoxycarbonyl- 3- phenylisoserinate)IBA
08/2005
1SesquiterpenesIBA
08/2005
1Paclitaxel (Taxol)FDA LinkGeneric
08/2005
1Pharmaceutical PreparationsIBA
07/2004
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
11/2002
1nimesulide (Aulin)IBA
11/2002

Therapy/Procedure

4Therapeutics
11/2013 - 08/2005
1Precision Medicine
08/2014
1Lasers (Laser)
07/2006